These characteristics make pro-NGF, NGF, TrkA and NGFR/p75NTR good candidates as diagnostic and prognostic tools and therapeutic targets for different types of breast cancer, as indicated by other lines of research. This evidence concerns the gene NGFR and breast cancer.